Xvivo Perfusion AB Owners

Health Care & Life Sciences » Biotechnology | Xvivo Perfusion AB

Xvivo Perfusion AB | Ownership

Companies that own Xvivo Perfusion AB

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Swedbank Robur Fonder AB

1,430,000

5.46%

0.03%

12/31/2017

Fjärde AP-fonden

1,100,000

4.2%

0.1%

12/31/2017

Norron AB

769,802

2.94%

-225,966

0.8%

08/31/2018

Catella Fondförvaltning AB

595,081

2.27%

-30,585

0.25%

08/31/2018

Tredje AP-fonden

406,408

1.55%

406,408

0.05%

06/30/2017

Financière de l'Échiquier SA

373,828

1.43%

373,828

0.12%

06/30/2017

Länsförsäkringar Fondförvaltning AB

292,757

1.12%

292,757

0.07%

07/31/2018

LähiTapiola Varainhoito Oy

276,079

1.05%

0.23%

05/31/2018

Strand Kapitalförvaltning AB

209,000

0.8%

8.28%

06/30/2017

E. Öhman J :or Fonder AB

132,839

0.51%

0.05%

12/31/2017

About Xvivo Perfusion AB

View Profile

Address	Mässans gata 10 Gothenburg VG 412 51 Sweden
Employees	-
Website	http://www.xvivoperfusion.com
Updated	07/08/2019
Xvivo Perfusion AB is a medical technology company which develops and markets solutions and systems for assessing the usability of organs, enabling the treatment of organs and maintaining organs in good condition outside the body pending transplantation. Its products include XPS, XPS Disposable Kit, Steen Solution, Organ Chamber, Lung Cannula Set, Perfadex, and Silicone Tubing Set. The company was founded on December 17, 1998 and is headquartered in Gothenburg, Sweden.